Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	30	9	5	8	9	3
Market Cap Growth	234.88%	70.79%	-33.85%	-12.43%	221.01%	-41.95%
Enterprise Value	29	9	5	8	8	3
Last Close Price	0.17	0.07	0.04	0.07	0.09	0.04
PB Ratio	21.04	20.15	3.70	5.48	4.81	9.32
P/TBV Ratio	21.04	20.15	3.70	5.48	4.81	9.32
Debt / Equity Ratio	0.03	0.13	0.03	0.02	0.02	0.88
Quick Ratio	0.49	0.11	0.06	0.10	1.39	0.02
Current Ratio	0.58	0.17	0.13	0.27	1.43	0.03
Return on Equity (ROE)	-261.78%	-181.07%	-96.50%	-104.07%	-185.44%	-214.90%
Return on Assets (ROA)	-52.14%	-39.76%	-35.90%	-43.03%	-64.23%	-49.37%
Return on Capital (ROIC)	-127.05%	-95.53%	-51.55%	-58.35%	-97.81%	-86.50%
Return on Capital Employed (ROCE)	-167.60%	-300.60%	-82.10%	-106.70%	-101.50%	-311.90%
Earnings Yield	-10.29%	-18.83%	-26.36%	-21.86%	-22.39%	-39.91%
FCF Yield	-8.91%	-5.17%	-21.97%	-24.94%	-22.77%	-15.21%
Buyback Yield / Dilution	-14.68%	-5.46%	-21.03%	-13.89%	-34.24%	-22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.